Funder
Science and Engineering Research Board
Publisher
Springer Science and Business Media LLC
Subject
Molecular Biology,Applied Microbiology and Biotechnology,Biochemistry,General Medicine,Bioengineering,Biotechnology
Reference62 articles.
1. Reck, M., Popat, S., Reinmuth, N., De Ruysscher, D., Kerr, K. M., & Peters, S. (2014). Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology, 25(suppl_3), 27–39.
2. Stoffel, A. (2010). Targeted therapies for solid tumors. BioDrugs, 24(5), 303–316.
3. Gerber, D. E. (2008). Targeted therapies: A new generation of cancer treatments. American Family Physician, 77(3), 311–319.
4. Soda, M., Choi, Y. L., Enomoto, M., Takada, S., Yamashita, Y., Ishikawa, S., Fujiwara, S. I., Watanabe, H., Kurashina, K., Hatanaka, H., & Bando, M. (2007). Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer. Nature, 448(7153), 561–566.
5. Facchinetti, F., Tiseo, M., Di Maio, M., Graziano, P., Bria, E., Rossi, G., & Novello, S. (2016). Tackling ALK in non-small cell lung cancer: the role of novel inhibitors. Translational lung cancer research, 5(3), 301–321.
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献